Efficacy and optimal combination timing of chemotherapy combined with PD-1 inhibitor in advanced cervical cancer: a multicenter retrospective cohort study

BACKGROUND: This study aimed to investigate the efficacy and safety of chemotherapy combined with programmed cell death protein 1 (PD-1) inhibitors in the treatment of advanced cervical cancer and the effect of optimal combination timing on prognosis. METHODS: From March 2020 to December 2021, the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yi-Ming, Cheng, Shu-Xia, Zhang, Ming-Chuan, Zhang, Hui-Ying, Gu, Jun-Jiao, Zhao, Pan-Pan, Ge, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652515/
https://www.ncbi.nlm.nih.gov/pubmed/36388810
http://dx.doi.org/10.21037/atm-22-4298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652515/
https://www.ncbi.nlm.nih.gov/pubmed/36388810
http://dx.doi.org/10.21037/atm-22-4298

Ejemplares similares